Source: Health Products Regulatory Authority (IE) Revision Year: 2021 Publisher: Teva B.V., Swensweg 5, 2031GA Haarlem, Netherlands
Axsain 0.075% w/w Cream.
| Pharmaceutical Form |
|---|
|
Cream. A smooth, white cream. |
Capsaicin 0.075% w/w.
Excipient(s) with known effect:
Each cream tube contains;
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Capsaicin |
Capsaicin, or 6-nonenamide, N-[(4-hydroxy-3-methoxyphenyl) methyl]-8-methyl, (6E), is a highly selective agonist for the transient receptor potential vanilloid 1 receptor (TRPV1). The initial effect of capsaicin is the activation of TRPV1-expressing cutaneous nociceptors, which results in pungency and erythema due to the release of vasoactive neuropeptides. |
| List of Excipients |
|---|
|
Purified Water |
Aluminium tubes with epoxyphenolic lining and polypropylene cap, containing 45g of cream.
Teva B.V., Swensweg 5, 2031GA Haarlem, Netherlands
PA1986/088/001
Date of first authorisation: 14 June 1994
Date of last renewal: 14 June 2009
| Drug | Countries | |
|---|---|---|
| AXSAIN | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
